Normal view MARC view ISBD view

Formulation development of a fixed dose combination tablets of metformin and pregabalin

By:

Material type: Text

TextPublication details: Islamabad (unpublished) 2022Description: xviii, 100 p. : ill. ; 30 cm. +CDSubject(s):

DDC classification:

Dissertation note: Thesis (M.Phil)--Riphah International University, 2022

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	Copy number	Status	Date due	Barcode
Thesis	City Campus	615.1 NOS (Browse shelf(Opens below))	1	NOT for LOAN		53180

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.1 NOK Evaluating colistin resistance prevalence and pharmacovigilance nephrotoxicity profile in infectious diseases	615.1 NOM Pharmacological investigation of brucine for therapeutic potential in gastric ulcer	615.1 NOO Formulation optimization & evaluation of gastroretentive floating bi-layered tablets of metformin & empagliflozin	615.1 NOS Formulation development of a fixed dose combination tablets of metformin and pregabalin	615.1 NOS Pharmacological investigation of bargepten in neuropsychiatric disorder	615.1 NOU Formulation of controlled-release baclofen matrix tablets and evaluation of the influence of different polymers on its release rate	615.1 NOU Formulation development of eudragit based enteric coated singled layer tablets of paroxetine hydrochloride	Next

Submitted in fulfillment of the requirement for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences.

Includes bibliographical references.

Thesis supervisor: Dr. Shahiq-uz-Zaman
Co-supervisor: Dr. Amna Niaz

Thesis (M.Phil)--Riphah International University, 2022

English

There are no comments on this title.

to post a comment.